Literature DB >> 26915576

Shift Work: A Risk Factor for Central Serous Chorioretinopathy.

Elodie Bousquet1, Myriam Dhundass2, Mathieu Lehmann2, Pierre-Raphaël Rothschild3, Virginie Bayon4, Damien Leger4, Ciara Bergin5, Ali Dirani5, Talal Beydoun2, Francine Behar-Cohen6.   

Abstract

PURPOSE: To investigate if shift work or sleep disturbances are risk factors for central serous chorioretinopathy (CSCR).
DESIGN: Prospective case-control study.
METHODS: Forty patients with active CSCR and 40 controls (age- and sex-matched) were prospectively recruited from the Ophthalmology Department of Hôtel Dieu Hospital, Paris, between November 2013 and December 2014. All patients were asked to complete a questionnaire addressing previously described risk factors and working hours, as well as the Insomnia Severity Index (ISI), a validated instrument for assessing sleep disturbances.
RESULTS: The mean age of the CSCR group was 44 ± 9 years, whereas the mean age of the control group was 43 ± 10 years. By use of multivariate analysis, shift work (odds ratio [OR] [95% confidence interval]: 5 [1.2-20.4]; P = .02), steroid use (OR: 5.5 [1.1-26.2]; P = .03), and recent psychological stress (OR: 15.3 [4.1-54.5]; P < .001) were found to be independently associated with CSCR.
CONCLUSION: The outcomes of this study suggest that shift work is an independent risk factor of CSCR. Further studies are required to confirm these results and to examine if work reconversion would be beneficial in the treatment of patients with chronic/recurrent CSCR.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26915576     DOI: 10.1016/j.ajo.2016.02.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses.

Authors:  Camila Q Felipe; Ana Luiza Biancardi; Vinicius T Civile; Nelson Carvas Junior; Pedro D Serracarbassa; Marcia K Koike
Journal:  Int J Retina Vitreous       Date:  2022-06-07

2.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

Review 3.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

4.  Poor Sleep Quality Is the Risk Factor for Central Serous Chorioretinopathy.

Authors:  Yuying Ji; Miaoling Li; Xiongze Zhang; Yuting Peng; Feng Wen
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

5.  Risk Factors for Persistent or Recurrent Central Serous Chorioretinopathy.

Authors:  Jia Yu; Gezhi Xu; Qing Chang; Xiaofeng Ye; Lei Li; Chunhui Jiang; Qi Zhao
Journal:  J Ophthalmol       Date:  2019-08-14       Impact factor: 1.909

6.  Increased Risk of Central Serous Chorioretinopathy among Patients with Nonorganic Sleep Disturbance.

Authors:  Peng-Tai Tien; Chien-Yu Lai; Chun-Ju Lin; Wen-Lu Chen; Po-Kang Lin; Chih-Hsin Muo; Yi-Yu Tsai; Lei Wan; Wen-Chao Ho; Hui-Ju Lin
Journal:  J Ophthalmol       Date:  2020-02-12       Impact factor: 1.909

7.  Personality Traits, Stress, and Emotional Intelligence Associated with Central Serous Chorioretinopathy.

Authors:  Anita Pusic Sesar; Antonio Sesar; Kajo Bucan; Irena Sesar; Katarina Cvitkovic; Ivan Cavar
Journal:  Med Sci Monit       Date:  2021-01-10

8.  Pupillary Responses Reveal Autonomic Regulation Impairments in Patients With Central Serous Chorioretinopathy.

Authors:  Xiaoyin Zhou; Hisashi Fukuyama; Yoichi Okita; Hiroyuki Kanda; Yuki Yamamoto; Takashi Araki; Fumi Gomi
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

9.  Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.

Authors:  Elodie Bousquet; Héloïse Torres-Villaros; Julien Provost; Martine Elalouf; Anthony Gigon; Irmela Mantel; Aurélie Timsit; Francine Behar-Cohen
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.